Induction of apoptosis by a combination of paclitaxel and carboplatin in the presence of hyperthermia

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 1, 2012, Pages 81-85

  Huang, Tao ^a   Gong, Wei Hua ^b   Li, Xiu Cheng ^a   Zou, Chun Ping ^a   Jiang, Guang Jian ^b   Li, Xu Hui ^b   Feng, Dian Peng ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Carboplatin; Osteosarcoma; Paclitaxel; Thermochemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; FAS ANTIGEN; FAS PROTEIN, HUMAN; PACLITAXEL;

APOPTOSIS; ARTICLE; BONE TUMOR; DRUG EFFECT; ENZYME IMMUNOASSAY; FEVER; HUMAN; METABOLISM; MULTIMODALITY CANCER THERAPY; OSTEOSARCOMA; PATHOLOGY; TUMOR CELL CULTURE;

ANTIGENS, CD95; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BONE NEOPLASMS; CARBOPLATIN; COMBINED MODALITY THERAPY; FEVER; HUMANS; IMMUNOENZYME TECHNIQUES; OSTEOSARCOMA; PACLITAXEL; TUMOR CELLS, CULTURED;

EID: 84864883909     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.1.081     Document Type: Article

References (28)

1. Andreou D, Bielack SS, Carrle D, et al (2011). The influence of tumor- and treatment-related factors on the development of local recurrence in osteosarcoma after adequate surgery. An analysis of 1355 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. Ann Oncol, 22, 1228-35.
2. Bacci G, Balladelli A, Palmerini E, et al (2008). Neoadjuvant chemotherapy for osteosarcoma of the extremities in preadolescentpatients: the Rizzoli Institute experience. J Pediatr Hematol Oncol, 30, 908-12.
3. Bacci G, Rocca M, Salone M, et al (2008). High grade osteosarcoma of the extremities with lung metastases at presentation: treatment with neoadjuvant chemotherapy and simultaneous resection of primary andmetastatic lesions. J Surg Oncol, 98, 415-20.
4. Bakshandeh-Bath A, Stoltz AS, Homann N, et al (2009). Preclinical and clinical aspects of carboplatin and gemcitabine combined withwhole-body hyperthermia for pancreatic adenocarcinoma. Anticancer Research, 29, 3069-77.
5. Debes A, Willers R, Göbel U, Wessalowski R (2005). Role of heat treatment in childhood cancers: distinct resistance profiles of solid tumor cell lines towards combined thermochemotherapy. Pediatr Blood Cancer, 45, 663-9.
6. de Bree E, Theodoropoulos PA, Rosing H, et al (2006). Treatment of ovarian cancer using intraperitoneal chemotherapy with taxanes: from laboratory bench to bedside. Cancer Treat Rev, 32, 471-82.
7. de Bree E, Rosing H, Michalakis J, et al (2006). Intraperitoneal chemotherapy with taxanes for ovarian cancer with peritoneal dissemination. Eur J Surg Oncol, 32, 666-70.
8. Drago-Ferrante R, Santulli A, Di Fiore R, et al (2008). Low doses of paclitaxel potently induce apoptosis in human retinoblastoma Y79 cells by up-regulating E2F1. Int J Oncol, 33, 677-87.
9. Franke M, Hardes J, Helmke K, et al (2010). Solitary skeletal osteosarcoma recurrence. Findings from the CooperativeOsteosarcoma Study Group. Pediatr Blood Cancer, 56, 771-6.
10. Fan QY, Ma BA, Zhou Y, Zhang MH, Hao XB (2003). Bone tumors of the extremities or pelvis treated by microwave-induced hyperthermia. Clin Orthop Relat Res, 406, 165-75.
11. Fiorillo A, DeRosa G, Giugliano F, et al (2009). Efficacy of pegylated lyposomal anthracyclines and of intra-arterial carboplatin and doxorubicin combined with local hyperthermia in a case of malignant endovascular papillary angioendothelioma. Curr Drug Deliv, 6, 58-61.
12. Goto T, Okuma T, Nakada I, Hozumi T, Kondo T (2007). Preoperative adjuvant therapy for primary malignant bone tumors. Gan To Kagaku Ryoho, 34, 1750-4.
13. Huisman C, Ferreira CG, Bröker LE, et al (2002). Paclitaxel triggers cell death primarily via caspase-independent routes in the non-small cell lung cancer cell line NCI-H460. Clin Cancer Res, 8, 596-606.
14. Kim HS, Lee YS, Kim DK (2009). Doxorubicin exerts cytotoxic effects through cell cycle arrest and Fas-mediated cell death. Pharmacology, 84, 300-9.
15. Liu B, Yang M, Li X, et al (2008). Enhanced efficiency of thermally targeted taxanes delivery in a human xenograft model of gastric cancer. J Pharm Sci, 97, 3170-81.
16. Li S, Zhou Y, Dong Y, CLEMENT IP (2007). Doxorubicin and selenium cooperatively induce fas signaling in the absence of Fas/Fas ligand interaction. Anticancer Res, 27, 3075-82.
17. Michalakis J, Georgatos SD, de Bree E, et al (2007). Short-term exposure of cancer cells to micromolar doses of paclitaxel, with or without hyperthermia, induces long-term inhibition of cell proliferation and cell death in vitro. Ann Surg Oncol, 14, 1220-8.
18. Mohamed F, Marchettini P, Stuart OA, Urano M, Sugarbaker PH (2003). Thermal enhancement of new chemotherapeutic agents at moderate hyperthermia. Ann Surg Oncol, 10, 463-8.
19. Mishima K, Nariai Y, Yoshimura Y (2003). Carboplatin induces Fas (APO-1/CD95)-dependent apoptosis of human tongue carcinoma cells: sensitization for apoptosis by upregulation of FADD expression. Int J Cancer, 105, 593-600.
20. Pires NMM, Eefting D, de Vries MR, Quax PHA, Wouter Jukema J (2007). Sirolimus and paclitaxel provoke different vascular pathological responses after local delivery in a murine model for restenosis on underlying atherosclerotic arteries. Heart, 93, 922-7.
21. Shido Y, Nishida Y, Suzuki Y, Kobayashi T, Ishiguro N (2010). Targeted hyperthermia using magnetite cationic liposomes and an alternating magnetic field in a mouse osteosarcoma model. J Bone Joint Surg Br, 92, 580-5.
22. Stumm S, Meyer A, Lindner M, et al (2004). Paclitaxel treatment of breast cancer cell lines modulates Fas/Fas ligand expression and induces apoptosis which can be inhibited through the CD40 receptor. Oncology, 66, 101-11.
23. Sirichaisutdhikorn D, Suprasert P, Khunamornpong S (2009). Clinical outcome of the ovarian clear cell carcinoma compared to other epithelial ovarian cancers when treated with paclitaxel and carboplatin. Asian Pac J Cancer Prev, 10, 1041-5.
24. Trieb K, Blahovec H, Kubista B (2007). Effects of hyperthermia on heat shock protein expression, alkaline phosphatase activity and proliferation in human osteosarcoma cells. Cell Biochem Funct, 25, 669-72.
25. Yu DY, Matsuya Y, Zhao QL, et al (2007). Enhancement of hyperthermia-induced apoptosis by a new synthesized class of furan-fused tetracyclic compounds. Apoptosis, 12, 1523-32.
26. Wang X, Gao XH, Li X, et al (2009). Local hyperthermia induces apoptosis of keratinocytes in both normal skin andcondyloma acuminata via different pathways. Apoptosis, 14, 721-8.
27. Zoul Z, Filip S, Melichar B, et al (2004). Weekly paclitaxel combined with local hyperthermia in the therapy of breast cancer locally recurrent after mastectomy--a pilot experience. Onkologie, 27, 385-8.
28. Zhou JN, Huang XE, Ye Z, et al (2009). Weekly paclitaxel/ docetaxel combined with a platinum in the treatment of advanced non-small cell lung cancer: a study on efficacy, safety and pre-medication. Asian Pac J Cancer Prev, 10, 1147-50.